VIRAREGEN Trademark

Trademark Overview


On Friday, July 19, 2024, a trademark application was filed for VIRAREGEN with the United States Patent and Trademark Office. The USPTO has given the VIRAREGEN trademark a serial number of 98657748. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, April 9, 2025. This trademark is owned by Vira Regen Inc.. The VIRAREGEN trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for accelerating bone and musculoskeletal tissue healing through regenerative and electroceutical therapies; medical devices for accelerating the treatment of genetic, neuro-muscular, orthopedic, neurologic, oncologic, and inflammatory conditions, diseases, and disorders through regenerative and electroceutical therapies; medical devices for accelerating bone and musculoskeletal tissue healing through electrostimulation and noninvasive stimulation therapies; medical devices for accelerating the treatment of genetic, neuro-muscular, orthopedic, neurologic, oncologic, and inflammatory conditions, diseases, and disorders through electrostimulation and noninvasive stimulation therapies; medical devices for use in regenerative and electroceutical therapies in treating genetic, neuro-muscular, orthopedic, neurologic, oncologic, and inflammatory conditions, diseases, and disorders; medical devices worn on the body to enhance and accelerate bone and musculoskeletal tissue heali...
viraregen

General Information


Serial Number98657748
Word MarkVIRAREGEN
Filing DateFriday, July 19, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, April 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2025

Trademark Statements


Pseudo MarkVIRA REGEN
Goods and ServicesMedical devices for accelerating bone and musculoskeletal tissue healing through regenerative and electroceutical therapies; medical devices for accelerating the treatment of genetic, neuro-muscular, orthopedic, neurologic, oncologic, and inflammatory conditions, diseases, and disorders through regenerative and electroceutical therapies; medical devices for accelerating bone and musculoskeletal tissue healing through electrostimulation and noninvasive stimulation therapies; medical devices for accelerating the treatment of genetic, neuro-muscular, orthopedic, neurologic, oncologic, and inflammatory conditions, diseases, and disorders through electrostimulation and noninvasive stimulation therapies; medical devices for use in regenerative and electroceutical therapies in treating genetic, neuro-muscular, orthopedic, neurologic, oncologic, and inflammatory conditions, diseases, and disorders; medical devices worn on the body to enhance and accelerate bone and musculoskeletal tissue healing; medical devices worn on the body to enhance and accelerate the treatment of genetic, neuromuscular, orthopedic, neurologic, oncologic, and inflammatory conditions, diseases, and disorders; therapeutic apparatus and devices for conducting electrostimulation and noninvasive stimulation therapies, also for use in regenerative and electroceutical therapies; electroactive medical devices for wound healing; medical device, namely, pulsed electromagnetic field therapy devices; pulsed electromagnetic field therapy devices for therapeutic purposes

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 19, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVira Regen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84103

Trademark Events


Event DateEvent Description
Friday, July 19, 2024NEW APPLICATION ENTERED
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 29, 2025ASSIGNED TO EXAMINER
Monday, February 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 3, 2025NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 3, 2025NON-FINAL ACTION WRITTEN